Status obesitas dan kadar gula darah pada usia produktif
Abstract
High blood sugar levels are one of the biomarkers of metabolic syndrome that can develop into degenerative diseases. Blood sugar levels can be influenced by obesity status. This study aims to analyze the relationship between obesity status and blood sugar levels in productive age in the working area of the Mangkubumi Health Center, Tasikmalaya City. This research method is an observational analytic with a cross-sectional approach. The sampling method was carried out by purposive sampling (selection of research locations) and stratified random sampling (sampling) by as many as 125 people of productive age (15-64 years) in Mangkubumi Village, Karikil Village, and Cipari Village. Data collection on obesity status (anthropometry) was conducted using a digital stepping scale (body weight) and stadiometer (height). Physical activity data collection was conducted using a questionnaire. Data collection on blood sugar levels (Fasting Blood Sugar/GDP) was done using a glucometer. Data analysis used the Chi-Square test. The results of the data analysis showed that there was a significant relationship between obesity status and blood sugar levels (p=0.000).
Kadar gula darah yang tinggi merupakan salah satu biomarker (penanda) sindrom metabolik yang dapat berkembang menjadi penyakit degeneratif. Kadar gula darah dapat dipengaruhi oleh status obesitas. Penelitian ini bertujuan untuk menganalisis hubungan status obesitas dengan kadar gula darah pada usia produktif di wilayah kerja Puskesmas Mangkubumi Kota Tasikmalaya tahun 2024. Metode penelitian ini merupakan analitik observasional dengan pendekatan cross sectional. Cara pengambilan sampel dilakukan dengan purposive sampling (pemilihan lokasi penelitian) dan stratified random sampling (pengambilan sampel) sebanyak 125 orang usia produktif (15-64 tahun) di Kelurahan Mangkubumi, Kelurahan Karikil, dan Kelurahan Cipari. Pengumpulan data status obesitas (antropometri) dilakukan menggunakan timbangan injak digital (berat badan) dan stadiometer (tinggi badan), pengumpulan data kadar gula darah (Gula Darah Puasa/GDP) dilakukan menggunakan glukometer. Analisis data menggunakan uji Chi-Square. Hasil analisis data menunjukkan bahwa terdapat hubungan yang signifikan antara status obesitas dan kadar gula darah (p=0,000).
Keywords
Full Text:
PDFReferences
N. F. Fahmi, N. Firdaus, and S. Rohmah, “Perbedaan Kadar Glukosa Menggunaan Darah dengan Antikoagulan dan Tanpa Antikoagulan Metode Poct Norma,” Jurnal Ilmiah Obsgin, vol. 12, no. 2, pp. 16–19, 2020.
Y. Cho and S. Y. Lee, “Useful Biomarkers of Metabolic Syndrome,” International Journal of Environmental Research and Public Health, vol. 19, no. 15003, pp. 1–4, 2022, doi: 10.3390/ijerph192215003.
World Health Organization (WHO), “Noncommunicable Diseases,” World Health Organization. Accessed: Jan. 20, 2024. [Online]. Available: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases
Kementerian Kesehatan RI (Kemenkes), “Hasil Riset Kesehatan Dasar (Riskesdas) Tahun 2018,” Jakarta, 2018.
M. Falah, L. Lismayanti, N. P. Sari, and A. I. Mu’ti, “Self management of type 2 diabetes mellitus patients in Tasikmalaya,” Media Keperawatan Indonesia, vol. 6, no. 2, p. 104, 2023, doi: 10.26714/mki.6.2.2023.104-109.
Dinas Kesehatan Kota Tasikmalaya (Dinkes), “Laporan Triwulan III Dinas Kesehatan Kota Tasikmalaya Tahun 2023,” Tasikmalaya, 2023.
S. N. Saxton, B. J. Clark, S. B. Withers, E. C. Eringa, and A. M. Heagerty, “Mechanistic links between obesity, diabetes, and blood pressure: Role of perivascular adipose tissue,” Physiological Reviews, vol. 99, no. 4, pp. 1701–1763, 2019, doi: 10.1152/physrev.00034.2018.
E. Suwinawati, H. Ardiani, and R. Ratnawati, “Hubungan Obesitas Dengan Kejadian Diabetes Melitus Tipe 2 Di Posbindu PTM Puskesmas Kendal Kabupaten Ngawi,” Journal of Health Science and Prevention, vol. 4, no. 2, pp. 79–84, Aug. 2020, doi: 10.29080/jhsp.v4i2.388.
J. I. Malone and B. C. Hansen, “Does obesity cause type 2 diabetes mellitus (T2DM)? Or is it the opposite?,” Pediatr Diabetes, vol. 20, no. 1, pp. 5–9, Feb. 2019, doi: 10.1111/pedi.12787.
S. adi Soelistijo, Pedoman Pengelolaan dan Pencegahan Diabetes Tipe 2 Dewasa di Indonesia. PB PERKENI, 2021.
A. Kautzky-Willer, M. Leutner, and J. Harreiter, “Sex Differences in Type 2 Diabetes,” Diabetologia, vol. 66, pp. 986–1002, 2023, doi: 10.4414/cvm.2023.02273.
T. Karlsson et al., “Contribution of Genetics to Visceral Adiposity and Its Relation to Cardiovascular and Metabolic Disease,” Nature Medicine, vol. 25, no. 9, pp. 1390–1395, 2019, doi: https://doi.org/10.1038/s41591-019-0563-7.
M. Roderka, S. Puri, and J. A. Batsis, “Addressing Obesity to Promote Healthy Aging,” Clinics in Geriatric Medicine, vol. 36, no. 4, pp. 631–643, 2020, doi: 10.1016/j.cger.2020.06.006.Addressing.
A. M. McKee and J. E. Morley, Obesity in the Ederly. South Dartmouth: Endotext, 2021.
X. Zhang, Y. Yue, S. Liu, X. Cong, W. Wang, and J. Li, “Relationship between BMI and Risk of Impaired Glucose Tolerance and Impaired Fasting Glucose in Chinese Adults: a Prospective Study,” BMC Public Health, vol. 23, no. 1, pp. 1–8, 2023, doi: 10.1186/s12889-022-14912-0.
S. van Vliet et al., “Obesity Is Associated With Increased Basal and Postprandial β-Cell Insulin Secretion Even in the Absence of Insulin Resistance,” Diabetes, vol. 69, no. 10, pp. 2112–2119, 2020, doi: 10.2337/db20-0377.
R. Paleva, “Mekanisme Resistensi Insulin Terkait Obesitas,” Jurnal Ilmiah Kesehatan Sandi Husada, vol. 10, no. 2, pp. 354–358, 2019, doi: 10.35816/jiskh.v10i2.190.
X. Jin et al., “Pathophysiology of Obesity and Its Associated Diseases,” Acta Pharmaceutica Sinica B, vol. 13, no. 6, pp. 2403–2424, 2023, doi: 10.1016/j.apsb.2023.01.012.
J. I. Malone and B. C. Hansen, “Does obesity cause type 2 diabetes mellitus (T2DM)? Or is it the opposite?,” Pediatric Diabetes, vol. 20, no. 1, pp. 5–9, 2019, doi: 10.1111/pedi.12787.
DOI: https://doi.org/10.37058/nsj.v3i1.11168
Refbacks
- There are currently no refbacks.
Nutrition Scientific Journal is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.